|
1
|
Jemal A, Siegel R, Xu J, et al: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: from dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bates RC and Mercurio AM: The
epithelial-mesenchymal transition (EMT) and colorectal cancer
progression. Cancer Biol Ther. 4:365–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brabletz T, Hlubek F, Spaderna S, et al:
Invasion and metastasis in colorectal cancer:
epithelial-mesenchymal transition, mesenchymal-epithelial
transition, stem cells and beta-catenin. Cells Tissues Organs.
179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bracken CP, Gregory PA, Khew-Goodall Y and
Goodall GJ: The role of microRNAs in metastasis and
epithelial-mesenchymal transition. Cell Mol Life Sci. 66:1682–1699.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Humphreys DT, Westman BJ, Martin DI and
Preiss T: MicroRNAs control translation initiation by inhibiting
eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc
Natl Acad Sci USA. 102:16961–16966. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicoloso MS, Spizzo R, Shimizu M, et al:
MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev
Cancer. 9:293–302. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sempere LF, Christensen M, Silahtaroglu A,
et al: Altered microRNA expression confined to specific epithelial
cell subpopulations in breast cancer. Cancer Res. 67:11612–11620.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schepeler T, Reinert JT, Ostenfeld MS, et
al: Diagnostic and prognostic microRNAs in stage II colon cancer.
Cancer Res. 68:6416–6424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sachdeva M and Mo YY: MicroRNA-145
suppresses cell invasion and metastasis by directly targeting mucin
1. Cancer Res. 70:378–387. 2010. View Article : Google Scholar :
|
|
15
|
Wang L, Tang H, Thayanithy V, et al: Gene
networks and microRNAs implicated in aggressive prostate cancer.
Cancer Res. 69:9490–9497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arndt GM, Dossey L, Cullen LM, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin R, Zhang S, Wu Y, et al: microRNA-145
suppresses lung adenocarcinoma-initiating cell proliferation by
targeting OCT4. Oncol Rep. 25:1747–1754. 2011.PubMed/NCBI
|
|
18
|
Thiery JP, Acloque H, Huang RY, et al:
Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lim J and Thiery JP:
Epithelial-mesenchymal transitions: insights from development.
Development. 139:3471–3486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Samavarchi-Tehrani P, Golipour A, David L,
et al: Functional genomics reveals a BMP-driven
mesenchymal-to-epithelial transition in the initiation of somatic
cell reprogramming. Cell Stem Cell. 7:64–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J and Ma L: MicroRNA control of
epithelial-mesenchymal transition and metastasis. Cancer Metastasis
Rev. 31:653–662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scholer H, Ruppert S, Suzuki N, Chowdhury
K and Gruss P: New type of POU domain in germ line-specific protein
Oct4. Nature. 344:435–439. 1990. View
Article : Google Scholar
|
|
23
|
Nichols J, Zevnik B, Anastassiadis K, et
al: Formation of pluripotent stemcells in the mammalian embryo
depends on the POU transcription factor Oct4. Cell. 95:379–391.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Jong J and Looijenga LH: Stem cell
marker OCT3/4 in tumor biology and germ cell tumor diagnostics:
history and future. Crit Rev Oncog. 12:171–203. 2006. View Article : Google Scholar
|
|
25
|
Kim RJ and Nam JS: OCT4 expression
enhances features of cancer stem cells in a mouse model of breast
cancer. Lab Anim Res. 27:147–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Zhang X, Wang X, et al:
Inhibition of LDH-A by lentivirus-mediated small interfering RNA
suppresses intestinal-type gastric cancer tumorigenicity through
the downregulation of Oct4. Cancer Lett. 321:45–54. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Z, Xu WR, Qian H, et al: Oct4, a
novel marker for human gastric cancer. J Surg Oncol. 99:414–419.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo Y, Liu S, Wang P, et al: Expression
profile of embryonic stem cell-associated genes Oct4, Sox2 and
Nanog in human gliomas. Histopathology. 59:763–775. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iida H, Suzuki M, Goitsuka R and Ueno H:
Hypoxia induces CD133 expression in human lung cancer cells by
up-regulation of OCT3/4 and SOX2. Int J Oncol. 40:71–79. 2012.
|
|
30
|
Chien AJ, Conrad WH and Moon RT: A Wnt
survival guide: from flies to human disease. J Invest Dermatol.
129:1614–1627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chien AJ and Moon RT: WNTS and WNT
receptors as therapeutic tools and targets in human disease
processes. Front Biosci. 12:448–457. 2007. View Article : Google Scholar
|
|
32
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu Y, Zheng S, An N, et al: β-catenin as a
potential key target for tumor suppression. Int J Cancer.
129:1541–1551. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Anson M, Crain-Denoyelle AM, Baud V, et
al: Oncogenic β-catenin triggers an inflammatory response that
determines the aggressiveness of hepatocellular carcinoma in mice.
J Clin Invest. 122:586–599. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Davidson KC, Adams AM, Goodson JM, et al:
Wnt/β-catenin signaling promotes differentiation, not self-renewal,
of human embryonic stem cells and is repressed by Oct4. Proc Natl
Acad Sci USA. 109:4485–4490. 2012. View Article : Google Scholar
|
